Pancreatic Cancer Research

ResearcherGeneral Hospital of Shenyang Military RegionNo recent work listed

Wenda Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-0703-0929; OpenAlex author ID A5100527540. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Evaluation of serum ATX and LPA as potential diagnostic biomarkers in patients with pancreatic cancer. Co-author DOI 10.1186/s12876-021-01635-6↗
  2. Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer in vitro. Last author DOI 10.3748/wjg.v23.i5.817↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongyu Li · 2 shared papers, 2017–2021 · strength 0.28
  2. Xiaozhong Guo · 1 shared paper, 2021 · strength 0.19
  3. Chen Jiang · 1 shared paper, 2021 · strength 0.19
  4. Jiang Chen · 1 shared paper, 2017 · strength 0.09
  5. Jiajun Zhao · 1 shared paper, 2017 · strength 0.09
  6. Xiaozhong Guo · 1 shared paper, 2017 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.